Schilling Wolfgang | Novartis Pharma Inc. Research Departments Of Core Technology And Transplantation
スポンサーリンク
概要
関連著者
-
SCHILLING Wolfgang
Novartis Pharma Inc., Research, Department of Core Technology
-
Schilling Wolfgang
Novartis Pharma Inc. Research Departments Of Core Technology And Transplantation
-
Schilling Wolfgang
Novartis Pharma Ag Research Drug Discovery Center And Central Technologies
-
Sanglier J‐j
Novartis Pharma Inc. Research Departments Of Core Technology And Transplantation
-
FEHR Theodor
Novartis Pharma Inc., Research, Department of Core Technology
-
OBERER Lukas
Novartis Pharma Inc., Research, Department of Core Technology
-
SCHULER Walter
Novartis Pharma Inc., Research, Departments of Core Technology and Transplantation
-
Schilling W
Novartis Pharma Ag Basel Che
-
Fehr T
Novartis Pharma Inc. Research Departments Of Core Technology And Transplantation
-
Oberer Lukas
Novartis Pharma Ag Research Deparment
-
Schuler Walter
Novartis Pharma Inc. Research Departments Of Core Technology And Transplantation
-
SANGLIER Jean-
Novartis Pharma Inc., Research, Department of Core Technology
-
QUESNIAUX Valerie
Novartis Pharma Inc., Research, Departments of Core Technology and Transplantation
-
ZENKE Gerhard
Novartis Pharma Inc., Research, Departments of Core Technology and Transplantation
-
GSCHWIND Liliane
Novartis Pharma Inc., Research, Departments of Core Technology and Transplantation
-
Oberer L
Novartis Pharma Ag Basel Che
-
Zenke Gerhard
Novartis Pharma Inc. Research Departments Of Core Technology And Transplantation
-
Gschwind Liliane
Novartis Pharma Inc. Research Departments Of Core Technology And Transplantation
-
Quesniaux Valerie
Novartis Pharma Inc. Research Departments Of Core Technology And Transplantation
-
SCHUPP Thomas
Novartis Pharma AG, Research Department
-
MEMMERT Klaus
Novartis Pharma AG, Research Department
-
HOFMANN Hans
Novartis Pharma AG, Research Department
-
KALLEN Jorg
Novartis Pharma Inc., Research, Department of Core Technology
-
MAHNKE Marion
Novartis Pharma Inc., Research, Departments of Core Technology and Transplantation
-
MAURER Claudine
Novartis Pharma Inc., Research, Departments of Core Technology and Transplantation
-
SANGLIER Jean-jacques
Novartis Pharma Inc., Preclinical Research
-
PONELLE Monique
Novartis Pharma Inc., Preclinical Research
-
WEHRLI Susi
Novartis Pharma Inc., Preclinical Research
-
ENZ Albert
Novartis Pharma Inc., Preclinical Research
-
Enz Albert
Novartis Pharma Inc. Preclinical Research
-
Wehrli Susi
Novartis Pharma Inc. Preclinical Research
-
Kallen Jorg
Novartis Pharma Inc. Research Department Of Core Technology
-
Oberer Lukas
Novartis Pharma Ag Research Drug Discovery Center And Central Technologies
-
Hofmann Hans
Novartis Pharma Ag Research Department
-
Hofmann Hans
Novartis Pharma Inc. Research Departments Of Core Technology And Transplantation
-
Schupp T
Novartis Pharma Ag Research Drug Discovery Center And Central Technologies
-
Schupp Thomas
Novartis Pharma Ag Research Department
-
Memmert K
Novartis Pharma Ag Basel Che
-
Memmert Klaus
Novartis Pharma Ag Research Department
-
Ponelle Monique
Novartis Pharma Inc. Preclinical Research
-
STRATMANN Ansgar
Novartis Pharma AG, Research, Drug Discovery Center and Central Technologies
-
TOUPET Christiane
Novartis Pharma AG, Research, Drug Discovery Center and Central Technologies
-
TRABER Rene
Novartis Pharma AG, Research, Drug Discovery Center and Central Technologies
-
Mahnke Marion
Novartis Pharma Inc. Research Departments Of Core Technology And Transplantation
-
Traber Rene
Novartis Pharma Ag Research Drug Discovery Center And Central Technologies
-
Maurer Claudine
Novartis Pharma Inc. Research Departments Of Core Technology And Transplantation
-
Stratmann Ansgar
Novartis Pharma Ag Research Drug Discovery Center And Central Technologies
-
Toupet Christiane
Novartis Pharma Ag Research Drug Discovery Center And Central Technologies
著作論文
- Sanglifehrins A, B, C and D, Novel Cyclophilin-binding Compounds Isolated from Streptomyces sp. A92-308110 II. Structure Elucidation, Stereochemistry and Physico-chemical Properties
- Sanglifehrins A, B, C and D, Novel Cyclophilin-binding Compounds Isolated from Streptomyces sp. A92-308110 I. Taxonomy, Fermentation, Isolation and Biological Activity
- Cymbimicin A and B, Two Novel Cyclophilin-binding Structures Isolated from Actinomycetes
- New Insights Rifamycin B Biosynthesis : Isolation of Proansamycin B and 34a-Deoxy-rifamycin W as Early Macrocyclic Intermediates Indicating Two Separated Biosynthetic Pathways